Newsroom
Sorted by: Latest
-
eDreams ODIGEO Prime Days Achieve Record Results as All-Travel Subscription Strategy Takes Hold
BARCELONA, Spain--(BUSINESS WIRE)--eDreams ODIGEO (hereinafter ‘the Company’ or ‘eDO’) (BME: EDR) (OTC: EDDRF), the world’s leading travel subscription platform, today announced that its latest ‘Prime Days’ campaign has achieved record results for new member acquisition. This performance was notably driven by significant growth across new product segments, particularly rail and accommodation, and remains firmly in line with the Company’s high-conviction growth plan and financial guidance. The 1...
-
NATIXIS UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name o...
-
Darwinbox Named a Leader in Gartner® Magic Quadrant for Talent Acquisition Suites
HYDERABAD, India--(BUSINESS WIRE)--Darwinbox, an AI-native HR technology platform, announced its debut as a Leader in the 2026 Gartner® Magic Quadrant™ for Talent Acquisition Suites....
-
Atamyo Therapeutics Presents Promising Results in the First Patients Treated With Its ATA-200 Gene Therapy in the Clinical Trial Targeting LGMD-R5 Limb-Girdle Muscular Dystrophy
EVRY, France--(BUSINESS WIRE)--Atamyo Therapeutics presents promising results in the first patients treated with its ATA-200 gene therapy...
-
FPT Strengthens Bavarian Presence with New Munich Office, Accelerating AI Transformation
MUNICH--(BUSINESS WIRE)--Global technology corporation FPT officially cut the ribbon on its latest office in Germany. This milestone reinforces the company's long-term commitment to delivering AI-driven services to its growing customer base across Germany and the wider European market. Situated in one of Europe’s most dynamic technological and manufacturing hubs, the Munich office strengthens FPT’s delivery capabilities and enables faster, more scalable engagement across the region. The move un...
-
Cadeler Installs First Complete Monopile Foundation at Ørsted’s Hornsea 3 Offshore Wind Farm
COPENHAGEN, Denmark--(BUSINESS WIRE)--Cadeler completes installation of the first fully commissioned monopile foundation at Ørsted’s Hornsea 3 offshore wind farm in the UK, marking a major milestone in the execution of one of the world’s largest offshore wind developments. The installation is the first of 197 monopile foundations Cadeler will transport and install as part of the company’s full transportation and installation (T&I) scope for the project. Once completed, Hornsea 3 will become...
-
Massachusetts Financial Services Company UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Massachusetts Financial Services Company (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficia...
-
Massachusetts Financial Services Company UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Massachusetts Financial Services Company (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficia...
-
Degron Therapeutics Closes $40 Million Series A Extension to Support Molecular Glue Degrader Clinical Development
SAN DIEGO & HANGZHOU, China & SHANGHAI, China--(BUSINESS WIRE)--Degron Therapeutics ("Degron"), a clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines targeting previously undruggable or insufficiently drugged proteins, today announced the closing of a $40 million Series A Extension. The round was led by LAPAM CAPITAL. Additional investors include GTJA Investment Group, Fortune Capital, CSPC & Growth, ApicHope, GF Xinde, CASSTAR, Kinghall Ventures, and GAGE...
-
Telconet & C3ntro Partner to Launch CSN-2, a New Subsea AI Backbone
MEXICO CITY--(BUSINESS WIRE)--C3ntro Telecom and Telconet today announced a joint partnership to develop CSN-2, a next-generation subsea and terrestrial fiber optic network designed to connect North America's and Mexico's newest data center hubs. The submarine segment of CSN-2 will link Veracruz, Mexico, to Apalachee Beach, Florida, with a strategic branch to Galveston, Texas toward Houston, and another potential branch to Bonita Beach to interconnect with CSN-1, creating a new subsea route acr...